Andy Oram has a post at O'Reilly Radar about positive results from the Peer-to-Patent project, which he calls "one of the most audacious experiments in Internet activism in our day." Peer-to-Patent uses a wiki-style approach to determine whether patent claims are indeed new, inviting technology experts to look at patent applications and then post any prior art relevant to them. "First, people are signing up: over 2,000 so far. Second, they're submitting prior art: 202 pieces," Oram writes. "Most important: they're enjoying the work and would volunteer again."

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.